Quotient Sciences operates as an integrated contract research and development organization specializing in small molecule drug development. The company combines formulation development, clinical pharmacology testing, and manufacturing under one roof, enabling pharmaceutical and biotech companies to advance therapies from candidate selection through first in human trials to commercial production. By eliminating the silos that typically slow drug development, Quotient Sciences helps bring new treatments to patients faster. Their Translational Pharmaceutics platform integrates real time manufacturing with clinical testing, allowing critical decisions earlier in the development pathway and reducing time and cost to bring molecules to cure.
1300
Team Members
1990
Founded
Contract Research
Sector
On-Site
Work Environment
A world where every promising molecule reaches patients without delay, transforming medical possibility into accessible reality for those who need treatment most.
At Quotient Sciences, our mission is to accelerate the transformation of molecules into cures by integrating drug development capabilities and eliminating the silos that slow progress to patients.